Form 4: Rhythm Pharmaceuticals Executive Receives Stock Grant
Insider Transaction (Form 4)
Manher Joshi, Chief Medical Officer of Rhythm Pharmaceuticals, Inc., reported multiple transactions in common stock on August 17, 2026.
Summary
- Grant/award: acquired 50,000 Stock Options (Right to Buy) on August 17, 2026; holds 50,000 after (Direct).
- Grant/award: acquired 25,000 Restricted Stock Units on August 17, 2026; holds 25,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Manher Joshi — Officer (Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-17 | Grant/award | Stock Options (Right to Buy) | 50,000 | — | — | 50,000 |
| 2026-08-17 | Grant/award | Restricted Stock Units | 25,000 | — | — | 25,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-17 | Grant/award (50,000 shares) |
| 2026-08-17 | Grant/award (25,000 shares) |
Keywords
insider transaction, Form 4, RYTM, RHYTHM PHARMACEUTICALS, INC., neutral, Manher Joshi
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.